Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. (From -To)
REPORT DATE (DD-MM-YYYY)
01-06-2005
REPORT TYPE
Final
DATES COVERED
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER
SRI InternationalMenlo Park, California 94025-3493
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTWe are investigating a new approach to detection of breast cancer using optical vascular function imaging. Research on cancer therapy has revealed unusual properties of tumor vasculature produced through angiogenesis that have high promise for breast cancer detection. We are using this unusual behavior as a contrast mechanism by performing optical imaging during administration of different levels of oxygen and carbon dioxide. We have constructed imaging systems using immersion in a tissue phantom, improved the sensitivity and speed of the imaging systems and used mass flow controllers to regulate inhalation gas compositions, imaged 5 different cancer models, and compared dynamic and static measurements. Our results support our hypothesis that the additional contrast from imaging vascular function is superior to static (conventional) optical imaging. The results of this IDEA project have been the basis of additional funding for clinical testing. We believe that this approach can form the basis for a cancer imaging modality combining high sensitivity and specificity. New, sensitive, specific, and low cost imaging technologies are very important for detection and treatment of breast cancer, and should lead to reduced morbidity and mortality from this disease.
INTRODUCTIONWe are investigating a new approach to detection of breast cancer using optical vascular function imaging. Research on cancer therapy has revealed unusual properties of tumor vasculature produced through angiogenesis that have high promise for breast cancer detection.We are using this unusual behavior as a contrast...